CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Biocon, Viatris to sell reciprocal insulin for diabetics in US

By Munikoti Rochan

14:13, 16 November 2021

Biocon logo shown on computer screen
Biocon logo - Photo: Shutterstock

Indian pharmaceutical major Biocon and Nasdaq-traded health-care company Viatris said on Tuesday they have rolled out two products in the United States, meant for patients who have diabetes.

Subsidiary Biocon Biologics and Viatris will sell a SEMGLEE injection, a branded product, and an Insulin Glargine injection, an unbranded product, which help control high blood sugar in patients with Type 1 and Type 2 diabetes.

Both products are available in vial and filled pen presentations, and are interchangeable for the reference brand, LANTUS, allowing for substitution at the pharmacy counter, per a 16 November stock market statement.

One in five people live with diabetes

“At Biocon Biologics we are committed to expanding access to high-quality, affordable biologics to patients worldwide,” said Biocon Biologics deputy chief executive Shreehas Tambe. “The launch of our interchangeable biosimilar insulin glargine in the US by our partner Viatris is in line with our aspiration to provide our biosimilar insulins to ‘one in five’ insulin dependent people with diabetes, globally.”

Diabetes is a disease in which a person’s body either can't produce insulin or can't properly use the insulin it produces turn blood glucose (sugar) into energy the body can use. High blood sugar levels can lead to other health problems.

Oil - Crude

72.51 Price
-1.260% 1D Chg, %
Long position overnight fee -0.0225%
Short position overnight fee 0.0006%
Overnight fee time 22:00 (UTC)
Spread 0.040


43,877.35 Price
+4.190% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00


0.63 Price
-0.630% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168


15,884.20 Price
+0.400% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 22:00 (UTC)
Spread 1.8

“Viatris has a long-standing commitment to improving patient access to sustainable, quality and more affordable health care,” said Viatris’ head of North America Jose Cotarelo. “We are pleased to also offer a broad range of options to help patients, which are intended to maximise access to these important medicines, regardless of financial circumstances, insurance or channel.”

From lab to market

Biocon Biologics employs 4,800 people. Five molecules from the firm’s portfolio have been taken from the lab to the market in developed markets like the US, Australia, Canada, Japan and the European Union.

Viatris has a global workforce of about 38,000. The company’s portfolio comprises over 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases.

Earlier today, Bengaluru, India-headquartered Biocon’s shares finished 1.87% higher at INR368.50 ($4.95) on the National Stock Exchange, valuing the drug maker at around INR438.3bn. The stock has fallen some 20% so far this year.

Read more: India’s Coromandel partners with ThyssenKrupp for new unit

Rate this article

The difference between trading assets and CFDs
The main difference between CFD trading and trading assets, such as commodities and stocks, is that you don’t own the underlying asset when you trade on a CFD.
You can still benefit if the market moves in your favour, or make a loss if it moves against you. However, with traditional trading you enter a contract to exchange the legal ownership of the individual shares or the commodities for money, and you own this until you sell it again.
CFDs are leveraged products, which means that you only need to deposit a percentage of the full value of the CFD trade in order to open a position. But with traditional trading, you buy the assets for the full amount. In the UK, there is no stamp duty on CFD trading, but there is when you buy stocks, for example.
CFDs attract overnight costs to hold the trades (unless you use 1-1 leverage), which makes them more suited to short-term trading opportunities. Stocks and commodities are more normally bought and held for longer. You might also pay a broker commission or fees when buying and selling assets direct and you’d need somewhere to store them safely.
Capital Com is an execution-only service provider. The material provided on this website is for information purposes only and should not be understood as an investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page then you do so entirely on your own risk.

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading